We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
28.39%
Holding
366
New
27
Increased
101
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$8.02M |
| 2 |
Goldman Sachs
GS
|
+$4.67M |
| 3 |
Citigroup
C
|
+$1.86M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.39M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$96.4M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$48.6M |
| 3 |
DELL
DELL INC
DELL
|
+$2.92M |
| 4 |
Cboe Global Markets
CBOE
|
+$822K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.14% |
| 2 | Financials | 11.65% |
| 3 | Technology | 11% |
| 4 | Energy | 9.38% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
AstraZeneca
AZN
$263B
| $1.82M | 0.18% |
30,648
+790
| +3% | +$42.9K |
|
127
Public Service Enterprise Group
PEG
$39.5B
| $1.77M | 0.17% |
55,147
+8,971
| +19% | +$297K |
|
|
KRFT
128
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $1.75M | 0.17% |
32,456
-940
| -3% | -$50.2K |
|
129
JPMorgan Chase
JPM
$947B
| $1.74M | 0.17% |
29,690
-7,393
| -20% | -$405K |
|
130
Edison International
EIX
$30.3B
| $1.73M | 0.17% |
37,285
-2,153
| -5% | -$102K |
|
131
Everest Group
EG
$15.4B
| $1.72M | 0.17% |
11,047
-190
| -2% | -$29K |
|
|
CB
132
DELISTED
CHUBB CORPORATION
CB
| $1.67M | 0.16% |
17,227
-450
| -3% | -$42K |
|
133
Assurant
AIZ
$13.7B
| $1.65M | 0.16% |
24,809
+2,087
| +9% | +$128K |
|
134
Unum
UNM
$13.8B
| $1.64M | 0.16% |
46,613
+6,017
| +15% | +$197K |
|
135
Arrow Electronics
ARW
$10.9B
| $1.59M | 0.15% |
29,375
+2,480
| +9% | +$126K |
|
136
Costco
COST
$422B
| $1.59M | 0.15% |
13,385
-317
| -2% | -$37.9K |
|
137
Norfolk Southern
NSC
$77.1B
| $1.58M | 0.15% |
16,991
+910
| +6% | +$78.1K |
|
138
Biogen
BIIB
$29.5B
| $1.56M | 0.15% |
5,564
-341
| -6% | -$88.2K |
|
139
Zimmer Biomet
ZBH
$17.8B
| $1.56M | 0.15% |
17,195
-51
| -0.3% | -$4.41K |
|
140
VF Corp
VFC
$6.72B
| $1.5M | 0.14% |
25,482
-138
| -0.5% | -$7.19K |
|
141
iShares MSCI KLD 400 Social ETF
DSI
$5.15B
| $1.49M | 0.14% |
43,216
| – | – |
|
142
Caterpillar
CAT
$402B
| $1.47M | 0.14% |
16,234
-281
| -2% | -$24K |
|
|
143
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $1.44M | 0.14% |
+53,765
| New | +$1.39M |
|
144
Molson Coors Class B
TAP
$7.71B
| $1.44M | 0.14% |
25,552
-298
| -1% | -$15.9K |
|
145
MGM Resorts International
MGM
$11.8B
| $1.43M | 0.14% |
60,755
-3,630
| -6% | -$74K |
|
146
International Paper
IP
$22.5B
| $1.42M | 0.14% |
30,999
-2,613
| -8% | -$112K |
|
147
GameStop
GME
$9.66B
| $1.41M | 0.14% |
114,352
-5,644
| -5% | -$72.4K |
|
|
148
iShares Russell 2000 ETF
IWM
$80.3B
| $1.37M | 0.13% |
+11,863
| New | +$1.31M |
|
149
Kohl's
KSS
$2.1B
| $1.35M | 0.13% |
23,834
+1,667
| +8% | +$91.4K |
|
150
Lear
LEA
$7.26B
| $1.34M | 0.13% |
16,537
+3,807
| +30% | +$298K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q4 2013 Portfolio in Review
As of Q4 2013, RegentAtlantic Capital held 366 positions worth $1.04B, up 13% from $917M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
RegentAtlantic Capital withdrew a net $117M in Q4 2013, closing 13 positions and reducing 180 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $96.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, RegentAtlantic Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $7.23M.
- RegentAtlantic Capital's largest Q4 2013 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 193,454 shares worth $7.23M.
- RegentAtlantic Capital added most to Goldman Sachs in Q4 2013, an estimated $4.67M increase.
- RegentAtlantic Capital's biggest Q4 2013 reduction was Cboe Global Markets, cutting an estimated $822K.
- RegentAtlantic Capital fully exited iShare MSCI Eurozone ETF in Q4 2013, selling an estimated $96.4M.
- RegentAtlantic Capital's ten largest holdings make up 28% of its $1.04B portfolio in Q4 2013.
- RegentAtlantic Capital opened 27 new positions and closed 13 in Q4 2013.
- RegentAtlantic Capital's portfolio value rose 13% quarter-over-quarter to $1.04B.
Based on RegentAtlantic Capital's 13F filing for Q4 2013, filed 31 Jan 2014.